We are thrilled to announce that 4M Therapeutics has filed provisional patents covering two of our assets — 4MT-01 and 4MT-02.
This milestone represents a major step forward for our company. We look forward to announcing more patent filings fortifying our intellectual property position further in the coming months.
4M Therapeutics Files Provisional Patents
Previous
Previous
Don Hayden and Lawrence Goldstein join 4M Therapeutics Inc. Board of Directors
Next
Next